Stocksigma LogoStocksigma Logo

Sun Pharma Board Meeting Scheduled for 30th Oct'26 to Consider Q2 Results

Sun Pharmaceutical Industries announced that its Board of Directors will meet on 30th Oct'26 to consider and approve the unaudited standalone and

Sun Pharma Board Meeting Scheduled for 30th Oct'26 to Consider Q2 Results

Sun Pharmaceutical Industries Ltd 路 Intimation 路 30 Oct 2026, 5:30 am

Sun Pharma Board Meeting Scheduled for 30th Oct'26 to Consider Q2 Results Sun Pharmaceutical Industries announced that its Board of Directors will meet on 30th Oct'26 to consider and approve the unaudited standalone and consolidated financial results for the quarter and half-year ended 30th Sep'26. Consequently, the trading window for dealing in company securities, closed since 1st Oct'26, will remain shut until 1st Nov'26 (48 hours post-declaration of results).

Original exchange filing (PDF)

More announcements from Sun Pharmaceutical Industries Ltd

All Sun Pharmaceutical Industries Ltd announcements